These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: combination therapy for the future. Leon MB; Bakhai A; Am Heart J; 2003 Oct; 146(4 Suppl):S13-7. PubMed ID: 14564301 [TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of drug-eluting stents: current best available evidence. Raja SG; Dreyfus GD J Card Surg; 2006; 21(6):605-12; discussion 613-4. PubMed ID: 17073969 [TBL] [Abstract][Full Text] [Related]
45. Polymer-based paclitaxel-eluting stents in percutaneous coronary intervention: a review of the TAXUS trials. Halkin A; Stone GW J Interv Cardiol; 2004 Oct; 17(5):271-82. PubMed ID: 15491330 [TBL] [Abstract][Full Text] [Related]
46. Understanding the drug-eluting stent trials. Coolong A; Kuntz RE Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349 [TBL] [Abstract][Full Text] [Related]
47. Are drug-eluting stents cost-effective? It depends on whom you ask. Ryan J; Cohen DJ Circulation; 2006 Oct; 114(16):1736-43; discussion 1744. PubMed ID: 17043177 [No Abstract] [Full Text] [Related]
48. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials]. Silber S; Herdeg C Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314 [TBL] [Abstract][Full Text] [Related]
49. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions. Ray GM; Nawarskas JJ; Frishman WH Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023 [TBL] [Abstract][Full Text] [Related]
50. Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. Daemen J; Simoons ML; Wijns W; Bagust A; Bos G; Bowen JM; Braunwald E; Camenzind E; Chevaliers B; DiMario C; Fajadeto J; Gitt A; Guagliumi G; Hillege HL; James S; Jüni P; Kastrati A; Kloth S; Kristensen SD; Krucoff M; Legrand V; Pfisterer M; Rothman M; Serruys PW; Silber S; Steg PG; Tariah I; Wallentin L; Windecker SW; Aimonetti A; Allocco D; Berenger M; Boam A; Calle JP; Campo G; Carlier S; de Schepper J; Di Bisceglie G; Dobbels H; Farb A; Ghislain JC; Hellbardt S; ten Hoedt R; Isaia C; de Jong P; Lekehal M; LeNarz L; Mhullain FN; Nagai H; Patteet A; Paunovic D; Potgieter A; Purdy I; Raveau-Landon C; Ternstrom S; Van Wuytswinkel J; Waliszewski M; EuroIntervention; 2009 Jan; 4(4):427-36. PubMed ID: 19284063 [No Abstract] [Full Text] [Related]
51. Treating multivessel disease in the era of coated stents: conclusion. Di Mario C; Griffiths H Heart; 2004 Sep; 90(9):1003. PubMed ID: 15310685 [No Abstract] [Full Text] [Related]
52. [Radioactive stents]. Di Mario C; Albiero R; Marsico F; Airoldi F; Vaghetti M; Corvaja N; Colombo A Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):475-80. PubMed ID: 12497955 [No Abstract] [Full Text] [Related]
57. Hippocrates revisited: the evidence for drug-eluting stents. Kereiakes DJ Circulation; 2003 Jun; 107(24):3012-4. PubMed ID: 12821588 [No Abstract] [Full Text] [Related]
58. Drug-eluting stents: new era and new concerns. Bhatia V; Bhatia R; Dhindsa M Postgrad Med J; 2004 Jan; 80(939):13-8. PubMed ID: 14760171 [TBL] [Abstract][Full Text] [Related]